• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[具体基因名称]多态性与[另一基因名称]多态性对脂质代谢的相加效应。 (你原文中“and”前后应该是基因名称之类的,这里我先按格式补充完整,你可根据实际修改)

The additive effects of the and polymorphisms on lipid metabolism.

作者信息

Chen Lizhen, Du Shuixian, Lu Linlin, Lin Zhonghua, Jin Wenwen, Hu Doudou, Jiang Xiangjun, Xin Yongning, Xuan Shiying

机构信息

College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, Shandong, China.

Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China.

出版信息

Oncotarget. 2017 Jun 14;8(43):74209-74216. doi: 10.18632/oncotarget.18474. eCollection 2017 Sep 26.

DOI:10.18632/oncotarget.18474
PMID:29088779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5650334/
Abstract

There is a genetic susceptibility for nonalcoholic fatty liver disease (NAFLD). To examine the role of genetic factors in the disease, a Bayesian analysis was performed to model gene relationships in NAFLD pathogenesis. The Bayesian analysis indicated a potential gene interaction between the and genes. Next, to explore the underlying mechanism at the cellular level, we evaluated the additive effects between the and polymorphisms on lipid metabolism. Hepa 1-6 cells were transfected with a control vector or with overexpression vectors for TM6SF2/PNPLA3-wild type, TM6SF2-mutant type, PNPLA3-mutant type, or TM6SF2/PNPLA3-mutant type. Commercial kits were used to measure triglyceride and total cholesterol levels in each of the five groups. The mRNA and protein expression levels of sterol regulatory element-binding transcription factor 1c and fatty acid synthase were analyzed using real-time PCR and western blotting. The triglyceride and total cholesterol contents were significantly different among the groups. The triglyceride and total cholesterol contents and the sterol regulatory element-binding transcription factor 1c and fatty acid synthase mRNA and protein expression levels were significantly higher in the TM6SF2/PNPLA3-mutant type group than in the TM6SF2-mutant type group or the PNPLA3-mutant type group. The and polymorphisms may have additive effects on lipid metabolism by increasing the expression of sterol regulatory element-binding transcription factor 1c and fatty acid synthase.

摘要

非酒精性脂肪性肝病(NAFLD)存在遗传易感性。为了研究遗传因素在该疾病中的作用,进行了贝叶斯分析以建立NAFLD发病机制中的基因关系模型。贝叶斯分析表明[未提及的两个基因]之间存在潜在的基因相互作用。接下来,为了在细胞水平探索潜在机制,我们评估了[未提及的两个基因]多态性对脂质代谢的累加效应。将Hepa 1-6细胞用对照载体或TM6SF2/PNPLA3野生型、TM6SF2突变型、PNPLA3突变型或TM6SF2/PNPLA3突变型的过表达载体进行转染。使用商业试剂盒测量五组中每组的甘油三酯和总胆固醇水平。使用实时PCR和蛋白质印迹法分析固醇调节元件结合转录因子1c和脂肪酸合酶的mRNA和蛋白质表达水平。各组之间甘油三酯和总胆固醇含量存在显著差异。TM6SF2/PNPLA3突变型组中的甘油三酯和总胆固醇含量以及固醇调节元件结合转录因子1c和脂肪酸合酶的mRNA和蛋白质表达水平显著高于TM6SF2突变型组或PNPLA3突变型组。[未提及的两个基因]多态性可能通过增加固醇调节元件结合转录因子1c和脂肪酸合酶的表达对脂质代谢产生累加效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/3f20998a246b/oncotarget-08-74209-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/4d5090037ae4/oncotarget-08-74209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/c0220693c6b6/oncotarget-08-74209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/a62a7f44ebd9/oncotarget-08-74209-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/f2a52817c039/oncotarget-08-74209-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/3f20998a246b/oncotarget-08-74209-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/4d5090037ae4/oncotarget-08-74209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/c0220693c6b6/oncotarget-08-74209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/a62a7f44ebd9/oncotarget-08-74209-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/f2a52817c039/oncotarget-08-74209-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/5650334/3f20998a246b/oncotarget-08-74209-g005.jpg

相似文献

1
The additive effects of the and polymorphisms on lipid metabolism.[具体基因名称]多态性与[另一基因名称]多态性对脂质代谢的相加效应。 (你原文中“and”前后应该是基因名称之类的,这里我先按格式补充完整,你可根据实际修改)
Oncotarget. 2017 Jun 14;8(43):74209-74216. doi: 10.18632/oncotarget.18474. eCollection 2017 Sep 26.
2
Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.载脂蛋白基因 I148M 及 TM6SF2 基因 E167K 变异与非酒精性脂肪性肝病患者冠心病风险的独立及联合相关性。
Lipids Health Dis. 2020 Feb 24;19(1):29. doi: 10.1186/s12944-020-01207-9.
3
Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.TM6SF2 E167K 和 PNPLA3 I148M 变异体在东北地区非酒精性脂肪性肝病中的相互作用。
Ann Hepatol. 2019 May-Jun;18(3):456-460. doi: 10.1016/j.aohep.2018.10.005. Epub 2019 Apr 15.
4
Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China.在中国青岛汉族人群中,结合 I148M 和 E167K 变异可提高非酒精性脂肪性肝病风险预测。
Lipids Health Dis. 2019 Feb 9;18(1):45. doi: 10.1186/s12944-019-0992-9.
5
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.PNPLA3基因的p.I148M变异与减肥手术后肝脏脂肪含量的更大幅度降低有关。
Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846. doi: 10.1016/j.soard.2016.06.004. Epub 2016 Jul 1.
6
Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.热量摄入减少可能会抵消脂肪肝患者中PNPLA3基因p.I148M和TM6SF2基因p.E167K变异的促脂肪变性作用:基于超声的前瞻性研究
Digestion. 2016;93(2):139-48. doi: 10.1159/000441185. Epub 2016 Jan 9.
7
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.治疗非酒精性脂肪性肝病中的肝脂肪和血清甘油三酯水平,PNPLA3 和 TM6SF2 基因型的影响:来自 WELCOME 试验的结果。
J Hepatol. 2015 Dec;63(6):1476-83. doi: 10.1016/j.jhep.2015.07.036. Epub 2015 Aug 10.
8
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.循环三酰甘油特征与 TM6SF2 中的 E167K 变异相关的非酒精性脂肪性肝病患者的胰岛素敏感性。
J Hepatol. 2015 Mar;62(3):657-63. doi: 10.1016/j.jhep.2014.10.010. Epub 2014 Oct 19.
9
PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.载脂蛋白基因 PNPLA3 I148M 和 TM6SF2 E167K 变异与胆汁淤积性肝病肝损伤无关:PSC 患者 178 例前瞻性分析。
PLoS One. 2018 Aug 30;13(8):e0202942. doi: 10.1371/journal.pone.0202942. eCollection 2018.
10
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.TM6SF2/PNPLA3/MBOAT7 基因功能丧失性变异对非酒精性脂肪性肝病发生发展的影响:在患者和体外模型中的研究。
Cell Mol Gastroenterol Hepatol. 2022;13(3):759-788. doi: 10.1016/j.jcmgh.2021.11.007. Epub 2021 Nov 23.

引用本文的文献

1
Genetics Is of the Essence to Face NAFLD.遗传学对于应对非酒精性脂肪性肝病至关重要。
Biomedicines. 2021 Sep 30;9(10):1359. doi: 10.3390/biomedicines9101359.
2
Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2.载脂蛋白 B 和 TM6SF2 上的 PCSK9 水平的元 GWAS 检测到两个新的位点。
Hum Mol Genet. 2022 Mar 21;31(6):999-1011. doi: 10.1093/hmg/ddab279.
3
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis.胆固醇稳定肝细胞中的 TAZ 以促进实验性非酒精性脂肪性肝炎。

本文引用的文献

1
Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.PNPLA3和TM6SF2风险等位基因对中国人群非酒精性脂肪性肝病(NAFLD)的累加效应
Front Genet. 2016 Aug 2;7:140. doi: 10.3389/fgene.2016.00140. eCollection 2016.
2
The role of the gut microbiota in NAFLD.肠道微生物群在非酒精性脂肪性肝病中的作用。
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25. doi: 10.1038/nrgastro.2016.85. Epub 2016 Jun 8.
3
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
Cell Metab. 2020 May 5;31(5):969-986.e7. doi: 10.1016/j.cmet.2020.03.010. Epub 2020 Apr 6.
4
Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China.在中国青岛汉族人群中,结合 I148M 和 E167K 变异可提高非酒精性脂肪性肝病风险预测。
Lipids Health Dis. 2019 Feb 9;18(1):45. doi: 10.1186/s12944-019-0992-9.
5
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?ω-3 脂肪酸与成人和儿童非酒精性脂肪性肝病:我们的立场如何?
Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):103-110. doi: 10.1097/MCO.0000000000000539.
6
The Genetics of Clinical Liver Diseases: Insight into the E167K Variant.临床肝脏疾病的遗传学:对E167K变体的见解
J Clin Transl Hepatol. 2018 Sep 28;6(3):326-331. doi: 10.14218/JCTH.2018.00022. Epub 2018 Sep 7.
7
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.PNPLA3 基因多态性与 HCV/HIV 共感染个体。
Dig Dis Sci. 2018 Nov;63(11):2969-2974. doi: 10.1007/s10620-018-5278-y. Epub 2018 Sep 14.
欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
4
Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.Tm6sf2(一种在脂肪肝疾病中存在缺陷的基因)的失活会损害极低密度脂蛋白的脂化过程,但不会影响其分泌。
J Biol Chem. 2016 May 13;291(20):10659-76. doi: 10.1074/jbc.M116.719955. Epub 2016 Mar 24.
5
TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.TM6SF2 E167K 变异体,一种新的遗传易感性变异体,与非酒精性脂肪性肝病有关。
J Clin Transl Hepatol. 2015 Dec 28;3(4):265-70. doi: 10.14218/JCTH.2015.00023. Epub 2015 Dec 15.
6
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
7
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children.跨膜6超家族成员2(TM6SF2)E167K变体增加肥胖儿童肝脂肪变性的易感性。
Dig Liver Dis. 2016 Jan;48(1):100-1. doi: 10.1016/j.dld.2015.10.003. Epub 2015 Oct 13.
8
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.一项全基因组关联研究证实了 PNPLA3 基因,并确定了 TM6SF2 和 MBOAT7 基因是与酒精性肝硬化相关的风险基因。
Nat Genet. 2015 Dec;47(12):1443-8. doi: 10.1038/ng.3417. Epub 2015 Oct 19.
9
Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.TM6SF2基因rs58542926位点在非酒精性小儿脂肪肝发病机制中的作用:一项多民族研究。
Hepatology. 2016 Jan;63(1):117-25. doi: 10.1002/hep.28283. Epub 2015 Nov 16.
10
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的循证临床实践指南。
J Gastroenterol. 2015 Apr;50(4):364-77. doi: 10.1007/s00535-015-1050-7. Epub 2015 Feb 24.